Cephalon's unusual NDA move.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D017387:Investigational New Drug Application; D018696:Neuroprotective Agents / Q000627:therapeutic use; D019782:Riluzole / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D018696:Neuroprotective Agents; C065700:myotrophin; D019782:Riluzole